Showing results (2371-2380 of 2,573) with videos related to
Sort By:
Pageof 258
Plos One|November 22, 2013
Executive function changes before memory in preclinical Alzheimer's pathology: a prospective, cross-sectional, case control studyMichael G Harrington, Jiarong Chiang, Janice M Pogoda, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 24, 2014
Parametric response mapping as an indicator of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantationCraig J Galbán, Jennifer L Boes, Maria Bule, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 25, 2012
Identifying and targeting ROS1 gene fusions in non-small cell lung cancerKurtis D Davies, Anh T Le, Mariana F Theodoro, et al.JCI Insight|August 23, 2022
Multiparametric MRI to quantify disease and treatment response in mice with myeloproliferative neoplasmsTanner H Robison, Manisha Solipuram, Kevin Heist, et al.Science Advances|July 25, 2025
Radiation with reproductive isolation in the near-absence of phylogenetic signalMartin Helmkampf, Floriane Coulmance, Melanie J Heckwolf, et al.Neurobiology of Disease|August 11, 2006
Elevated plasma triglyceride levels precede amyloid deposition in Alzheimer's disease mouse models with abundant A beta in plasmaBraydon L Burgess, Sean A McIsaac, Kathryn E Naus, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2021
Phase I Study of 2- or 3-Week Dosing of Telisotuzumab Vedotin, an Antibody-Drug Conjugate Targeting c-Met, Monotherapy in Patients with Advanced Non-Small Cell Lung CarcinomaD Ross Camidge, Daniel Morgensztern, Rebecca S Heist, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 13, 2012
A phase I/II study of erlotinib in combination with the anti-insulin-like growth factor-1 receptor monoclonal antibody IMC-A12 (cixutumumab) in patients with advanced non-small cell lung cancerAndrew Weickhardt, Robert Doebele, Ana Oton, et al.The Oncologist|July 21, 2021
First-In-Human, First-In-Class, Phase I Trial of the Fucosylation Inhibitor SGN-2FF in Patients with Advanced Solid TumorsKhanh T Do, Laura Quan Man Chow, Karen Reckamp, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 24, 2019
Updated Efficacy and Safety Data and Impact of the EML4-ALK Fusion Variant on the Efficacy of Alectinib in Untreated ALK-Positive Advanced Non-Small Cell Lung Cancer in the Global Phase III ALEX StudyD Ross Camidge, Rafal Dziadziuszko, Solange Peters, et al.Pageof 258